Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=onxxLatest Financial News for ONYX Pharmaceuticals, Inc.en-usWed, 30 Dec 2009 20:35:20 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12s10jnoc/*http%3A//www.fool.com/investing/value/2009/12/30/pfizer-pflubs-you-expected-otherwise.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2699611803Wed, 30 Dec 2009 20:35:20 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12t1475gd/*http%3A//www.fool.com/investing/high-growth/2009/12/18/3-reasons-to-buy-dendreon-today.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/680562435Fri, 18 Dec 2009 19:34:01 Etc/GMThttp://us.rd.yahoo.com/finance/external/minyanville/rss/SIG=1568716jj/*http%3A//www.minyanville.com/articles/multiple-myeloma-blood-cancer-research-stem-cell-transplant-chemotherapy-Alkeran-Revlimid-minyanville/index/a/25994/from/yahooThe stock soars on strong study results.yahoo_finance/899722828Fri, 18 Dec 2009 17:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091216/180201.html?.v=1yahoo_finance/3841065679Wed, 16 Dec 2009 15:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh50417_2009-12-12_02-00-49_n11160109_newsml&rpc=44&type=marketsNewsyahoo_finance/2690227874Sat, 12 Dec 2009 02:00:49 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091211/sf24728.html?.v=1Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced results from two collaborative group-sponsored randomized, double-blind, placebo-controlled Phase 2 trials were presented at the 32nd Annual San Antonio Breast Cancer Symposium .yahoo_finance/909740563Fri, 11 Dec 2009 21:45:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/blog/rss/SIG=11hoclqgt/*http%3A//www.cnbc.com/id/34383010/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/3808831398Fri, 11 Dec 2009 20:01:27 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091210/sf24438.html?.v=1Onyx Pharmaceuticals, Inc. today announced that it will host an Analyst Briefing on December 17, 2009 at 8:30 a.m. ET.yahoo_finance/3228021786Thu, 10 Dec 2009 21:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091209/28102.html?.v=1Onyx came out with positive data from a phase IIb study of carfilzomib at the 51st annual meeting of the American Society of Hematology in New Orleans.yahoo_finance/351794106Wed, 9 Dec 2009 16:02:58 Etc/GMThttp://us.rd.yahoo.com/finance/external/minyanville/rss/SIG=15477jgt9/*http%3A//www.minyanville.com/articles/American-Society-Hematology-meeting-research-treanda-carfilzomib-INCB424-myeloma-cancer-minyanville/index/a/25786/from/yahooCompanies making headlines at an annual hematology conference.yahoo_finance/1801430030Mon, 7 Dec 2009 20:20:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=137p1bgvb/*http%3A//www.fool.com/investing/high-growth/2009/12/07/when-the-big-guns-come-in-you-get-blasted.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2821990144Mon, 7 Dec 2009 20:10:30 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh85495_2009-12-07_18-07-35_n07169605_newsml&rpc=44&type=marketsNewsyahoo_finance/2052373632Mon, 7 Dec 2009 18:07:35 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091207/sf21784.html?.v=1Onyx Pharmaceuticals, Inc. today announced interim results from the Phase 1b/2 006 study, demonstrating that carfilzomib, when administered with the standard therapies lenalidomide and low dose dexamethasone, is active and well-tolerated in patients with relapsed and/or refractory multiple myeloma.yahoo_finance/64316023Mon, 7 Dec 2009 13:01:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091207/sf21782.html?.v=1Onyx Pharmaceuticals, Inc. today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib.yahoo_finance/2371896597Mon, 7 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091206/sf21687.html?.v=1Onyx Pharmaceuticals, Inc. today announced updated safety data from the pivotal Phase 2b 003-A1 study, known as the 003 trial, demonstrating that carfilzomib is well-tolerated in heavily pre-treated relapsed and refractory multiple myeloma patients.yahoo_finance/1448866028Sun, 6 Dec 2009 15:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=14124h1cl/*http%3A//www.thestreet.com/_yahoo/story/10639063/1/cramers-mad-money-recap-how-to-play-the-surprising-jobs-report-update-1.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1555932698Fri, 4 Dec 2009 23:39:12 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/blog/rss/SIG=11hpftt9h/*http%3A//www.cnbc.com/id/34280189/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/1063390154Fri, 4 Dec 2009 23:21:04 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091204/sf21367.html?.v=1Onyx Pharmaceuticals, Inc. today announced that it will host an investor teleconference and webcast.yahoo_finance/2316537837Fri, 4 Dec 2009 21:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=ONXXyahoo_finance/1351030186Thu, 3 Dec 2009 12:24:43 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091202/ny19637.html?.v=1S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans.yahoo_finance/1641315562Wed, 2 Dec 2009 12:00:00 Etc/GMT